References
- J. Noguchi and M. Gill, Sulbactam: a beta-lactamase inhibitor, Clin. Pharm. 7 (1988) 37–51.
- T. K. Jellison, P. S. McKinnon and M. J. Rybak, Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam, Pharmacotherapy 21 (2001) 142–148;
https://doi.org/10.1592/phco.21.2.142.34114 - D. M. Campoli-Richards and R. N. Brogden, Sulbactam/ampicillin, Drugs 33 (1987) 577–609;
https://doi.org/10.2165/00003495-198733060-00003 - M. C. Nahata, V. I. Vashi, R. N. Swanson, M. A. Messig and M. Chung, Pharmacokinetics of ampicillin and sulbactam in pediatric patients, Antimicrob. Agents Chemother. 43 (1999) 1225–1229;
https://doi.org/10.1128/AAC.43.5.1225 - A. Walsh, H. Edwards and J. Fraser, Over-the-counter medication use for childhood fever: a cross-sectional study of Australian parents, J. Paediatr. Child Health 43 (2007) 601–606;
https://doi.org/10.1111/j.1440-1754.2007.01161.x - S. Koling, G. Hempel, C. Lanvers, J. Boos and G. Würthwein, Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases, Int. J. Clin. Pharm. Ther. 45 (2007) 496–503;
https://doi.org/10.5414/cpp45496 - J. A. Forrest, J. Clements and L. Prescott, Clinical pharmacokinetics of paracetamol, Clin. Pharmacokinet. 7 (1982) 93–107.
- A. Bertolini, A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi and S. Leone, Paracetamol: new vistas of an old drug, CNS Drug Rev. 12 (2006) 250–275;
https://doi.org/10.1111/j.1527-3458.2006.00250.x - C. Oscier and Q. Milner, Peri-operative use of paracetamol, Anaesthesia 64 (2009) 65–72;
https://doi.org/10.1111/j.1365-2044.2008.05674.x - C. Gonzalez, A. Garcia, R. Urrea, H. Bello and R. Zemelman, A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria, Rev. Méd. Chile 118 (1990) 548–554.
- S. T. Shulman, A. L. Bisno, H. W. Clegg, M. A. Gerber, E. L. Kaplan, G. Lee, J. M. Martin and C. Van Beneden, Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America, Clin. Infect. Dis. 55 (2012) e86–e102;
https://doi.org/10.1093/cid/cis629 - S. L. Parker, S. Adnan, J. L. Ordóñez Meija, D. L. Paterson, J. Lipman, J. A. Roberts and S. C. Wallis, An UHPLC–MS/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma and urine, Bioanalysis 7 (2015) 2311–2319;
https://doi.org/10.4155/bio.15.143 - T. L. Tsou, Y. C. Huang, C. W. Lee, A. R. Lee, H. J. Wang and S. H. Chen, Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with β-cyclodextrin stationary phase, J. Sep. Sci. 30 (2007) 2407–2413;
https://doi.org/10.1002/jssc.200600529 - I. R. Miksa, M. R. Cummings and R. H. Poppenga, Multi-residue determination of anti-inflammatory analgesics in sera by liquid chromatography-mass spectrometry, J. Anal. Toxicol. 29 (2005) 95–104;
https://doi.org/10.1093/jat/29.2.95 - X. Chen, J. Huang, Z. Kong and D. Zhong, Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma, J. Chromatogr. B 817 (2005) 263–269;
https://doi.org/10.1016/j.jchromb.2004.12.011 - K. R. Ing-Lorenzini, J. A. Desmeules, M. Besson, J.-L. Veuthey, P. Dayer and Y. Daali, Two-dimensional liquid chromatography–ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: Application to a pharmacokinetic study, J. Chromatogr. A 1216 (2009) 3851–3856;
https://doi.org/10.1016/j.chroma.2009.02.071 - A. Gałuszka, Z. Migaszewski and J. Namieśnik, The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices, Trends Anal. Chem. 50 (2013) 78–84;
https://doi.org/10.1016/j.trac.2013.04.010 - M. Tobiszewski, A. Mechlińska and J. Namieśnik, Green analytical chemistry—theory and practice, Chem. Soc. Rev. 39 (2010) 2869–2878;
https://doi.org/10.1039/B926439F - L. H. Keith, L. U. Gron and J. L. Young, Green analytical methodologies, Chem. Rev. 107 (2007) 2695–2708;
https://doi.org/10.1021/cr068359e - A. Gałuszka, Z. M. Migaszewski, P. Konieczka and J. Namieśnik, Analytical eco-scale for assessing the greenness of analytical procedures, Trends Anal. Chem. 37 (2012) 61–72;
https://doi.org/10.1016/j.trac.2012.03.013 - G. Corcoran, J. Mitchell, Y. Vaishnav and E. Horning, Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine, Mol. Pharmacol. 18 (1980) 536–542.
- D. Nematollahi, Y. Nasseri, A. Amani and F. Fatemi, Kinetic and mechanistic study of drug-drug interaction between acetaminophen and β-lactam antibiotics, Progr. Reac. Kin. Mech. 38 (2013) 213–219;
https://doi.org/10.3184%2F146867813X13642226149240 - International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures: text and methodology, ICH, Geneva, November 2005.